An international research team has developed a new yeast-based biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before. It can reduce development time for new types of cancer immunotherapy from months to days or weeks.
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.